Skip to main content

Table 2 The characteristics of the children included in the test groups of children born prematurely (n = 19) and in children from other continents (n = 78).

From: The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children

  Preterm
(6 girls, 13 boys)
From foreign continents
(27 girls, 51 boys)
Variables Median Min Max n Median Min Max n
At birth         
Gestational age (weeks) 35 32 36 19 38.5 27 41 28
Height at birth SDS -2.55 -8.09 1.43 19 -1.76 -3.91 0.38 6
Weight at birth SDS -2.25 -6.12 0.11 19 -1.27 -3.95 0.63 8
At GH start         
Age at start of GH treatment (yrs) 6.38 3.02 10.1 19 8.35 3.13 13.47 78
Height SDS -2.81 -4.08 -2.01 19 -3.27 -6.31 -0.74 78
Weight SDS -2.78 -5.15 -1.56 19 -3.11 -5.66 1.12 78
Weight for height SDS -0.97 -3.29 0.71 19 -0.71 -3.8 4.23 78
BMI (kg/m2) 14.5 12.18 16.5 19 15.35 11.49 22.23 78
Change in height SDS during pre-treatment year 0 -0.45 0.52 17 0.07 -0.73 0.59 69
Target height SDS -0.58 -1.89 1.26 19 -1.23 -3.72 0.5 39
Father height SDS -1.13 -3.41 1.3 19 -2.04 -4.62 0.54 39
Mother height SDS -0.84 -3.39 1.55 19 -2.07 -5.85 0.4 41
Diff MPH SDS -2.23 -3.43 -1.27 19 -1.76 -4.35 1.27 39
GHmax during AITT (mU/L) 24.15 11 70.4 18 20.72 1.09 135.57 30
GHmax of 24 h profile (mU/L) 19.95 14.3 48.05 11 42.69 12.37 88.79 43
IGF-I at GH-start 60 19 187 18 78 12 259 19
IGF-I SDS -1.57 -5.42 0.72 18 -1.35 -7.02 1.75 19
GH dose (ug/kg.day) 0.037 0.027 0.043 19 0.033 0.023 0.047 78
During treatment         
Change in height SDS first yr 0.67 0.47 1.16 19 0.68 -0.1 1.74 78
Change in height SDS during 2 yrs 0.92 0.63 1.69 19 1.06 0.11 2.79 78